In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.
Aug 31, 2022
0
60
A team of University of British Columbia researchers working on developing oral insulin tablets as a replacement for daily insulin injections have made a game-changing discovery.
Aug 30, 2022
3
249
Tohoku University scientists in Japan have made a scaffold that supports the growth of new bone in large jaw defects in mice. Their findings, published in the journal PNAS Nexus, bring scientists one step closer to addressing ...
Aug 26, 2022
0
46
The benefits of a new COVID-19 booster that targets omicron variants far outweigh the possible risks, experts say.
Aug 25, 2022
0
25
Since the late 1800s non-nutritive sweeteners have promised to deliver all the sweetness of sugar with none of the calories. They have long been believed to have no effect on the human body, but researchers publishing in ...
Aug 19, 2022
0
1110
Researchers at Michigan Medicine have uncovered the molecular mechanism that drives the disease-causing effects of the most common genetic risk factor for lupus, a study suggests.
Aug 18, 2022
0
86
A new research perspective published in Oncoscienceexplores SLFN11's surveillance role in protein homeostasis.
Aug 3, 2022
0
6
A first of its kind comprehensive map of the network of connections that make up the human immune system has been created, which could lead to new immunotherapies to treat cancer, infectious diseases, and other conditions ...
Aug 3, 2022
0
101
Each year, over 2,000 women are diagnosed with breast cancer and more than 400 die from the disease (Singapore Cancer Registry annual report 2018). One in 13 women will get breast cancer in their lifetime.
Aug 2, 2022
0
299
Researchers in the Biomedical Engineering Department at UConn have developed a new cardiac cell-derived platform that closely mimics the human heart, unlocking potential for more thorough preclinical drug development and ...
Jul 28, 2022
0
40
